T2 Biosystems, Inc
TTOO
TTOO was delisted on the 11th of February, 2025.
34 hedge funds and large institutions have $107M invested in T2 Biosystems, Inc in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 7 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
1% less capital invested
Capital invested by funds: $108M → $107M (-$1.2M)
19% less funds holding
Funds holding: 42 → 34 (-8)
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $55K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$4.16M |
| 2 |
SM
Senvest Management
New York
|
+$1.69M |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$759K |
| 4 |
State Street
Boston,
Massachusetts
|
+$337K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$141K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.93M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$984K |
| 3 |
Morgan Stanley
New York
|
-$169K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$169K |
| 5 |
WC
Woodstock Corp
Boston,
Massachusetts
|
-$163K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WMSA
51
Weiss Multi-Strategy Advisers
New York
| – | -$132K | -5 | Closed |
|
52
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$3K | – | – |
|
53
Creative Planning
Overland Park,
Kansas
| – | -$9K | – | – |
|
|
GWM
54
Geneos Wealth Management
Englewood,
Colorado
| – | -$10K | – | – |
|
|
TRCT
55
Tower Research Capital (TRC)
New York
| – | -$1K | – | – |
|
TTOO Hedge Fund Activity: Q1 2017 in Review
34 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q1 2017, worth a combined $107M — down 1.1% from $108M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of TTOO and 3 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 7 added.
The largest buyer was BlackRock, opening a new position worth an estimated $4.16M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $1.93M sold.
- 34 institutional investors held T2 Biosystems, Inc (TTOO) as of Q1 2017, down from 42 in Q4 2016.
- Funds reported $107M of T2 Biosystems, Inc stock for Q1 2017, down 1.1% quarter-over-quarter.
- 3 funds opened new T2 Biosystems, Inc positions in Q1 2017 and 7 closed out, a net change of -4 holders.
- The largest T2 Biosystems, Inc buyer in Q1 2017 was BlackRock, an estimated $4.16M added.
- The largest T2 Biosystems, Inc seller in Q1 2017 was Point72 Asset Management, an estimated $1.93M sold.
Based on aggregated 13F filings for Q1 2017.